NeoImmuneTech, Inc.
A clinical-stage biopharma developing T cell-focused immuno-therapeutics for diseases.
950220 | KO
Overview
Corporate Details
- ISIN(s):
- KR8840140006
- LEI:
- Country:
- United States of America
- Address:
- 2400 Research Boulevard, Suite 250, Rockville, MD 20850, Rockville
- Website:
- https://www.neoimmunetech.com/en
Description
NeoImmuneTech, Inc. is a clinical-stage, T cell-focused biopharmaceutical company dedicated to the development of novel immuno-therapeutics. The company's lead asset is NT-I7 (efineptakin alfa), a long-acting human interleukin-7 (IL-7) fusion protein designed to amplify and reinvigorate T cells. This core technology aims to enhance the immune system's ability to eliminate cancer cells and pathogens. NT-I7 is being developed as a foundational immuno-oncology therapy for use in combination with other cancer treatments, such as checkpoint inhibitors, as well as for applications in infectious diseases. The company's research is focused on leveraging T cell amplification to address a wide range of challenging diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-12-16 00:00 |
기타경영사항(자율공시) (제11기 정기주주총회 권리주주 확정을 위한 증권예탁증권 기준일 설정 공고)
|
Korean | 4.9 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.1 MB | ||
| 2024-10-04 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 58.8 KB | ||
| 2024-09-30 00:00 |
증권발행결과(자율공시) (제1회차 CB)
|
Korean | 5.6 KB | ||
| 2024-09-25 00:00 |
주요사항보고서(전환사채권발행결정)
|
Korean | 152.5 KB | ||
| 2024-08-14 00:00 |
반기보고서 (2024.06)
|
Korean | 1.0 MB | ||
| 2024-08-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 173.3 KB | ||
| 2024-05-16 00:00 |
분기보고서 (2024.03)
|
Korean | 1016.0 KB | ||
| 2024-04-05 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 143.4 KB | ||
| 2024-04-05 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 93.4 KB | ||
| 2024-03-29 00:00 |
정기주주총회결과
|
Korean | 27.8 KB | ||
| 2024-03-29 00:00 |
대표이사변경
|
Korean | 10.1 KB | ||
| 2024-03-29 00:00 |
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 8.4 KB | ||
| 2024-03-29 00:00 |
주식매수선택권부여에관한신고
|
Korean | 14.6 KB | ||
| 2024-03-21 00:00 |
사업보고서 (2023.12)
|
Korean | 1.3 MB |
Automate Your Workflow. Get a real-time feed of all NeoImmuneTech, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NeoImmuneTech, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NeoImmuneTech, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
